Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.70 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.70 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.70 |
| ▸ | EFNA1 | P20827 | 1/20 | 0.70 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.70 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.70 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.70 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.70 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.70 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.70 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.70 |
| ▸ | MEN1 | O00255 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | INPP5D | Q92835 | 1/20 | 0.70 |
| ▸ | CDC25A | P30304 | 5/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL135273 | 1.00 | CYP2D6 (0.71) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| SCHEMBL28008854 | 1.00 | CYP2D6 (0.71) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| SCHEMBL288945 | 1.00 | CYP2D6 (0.71) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| SCHEMBL7126727 | 1.00 | CYP2D6 (0.71) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| SCHEMBL14676689 | 1.00 | CYP2D6 (0.71) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| SCHEMBL19866272 | 1.00 | CYP2D6 (0.71) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| SCHEMBL28898907 | 1.00 | CYP2D6 (0.71) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| Water SCHEMBL27578106 | 0.99 | CYP2D6 (0.70) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| Methane SCHEMBL27524872 | 0.99 | CYP2D6 (0.70) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| Ethane SCHEMBL8333555 | 0.99 | CYP2D6 (0.70) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113968891-B | Preparation method of plant source 7-ketolithocholic acid | 湖南科瑞生物制药股份有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-113968891-A | Preparation method of plant source 7-ketolithocholic acid | 湖南科瑞生物制药股份有限公司 | 2022-01-25 | — | — | CN | claimed |
| CN-1242017-A | Meiosis regulating compounds | NOVO NORDISK AS (DK) | 2000-01-19 | — | — | CN | claimed |
| WO-1993004672-A1 | METHOD FOR ENHANCING THE IMMUNE SYSTEM IN A HOST EMPLOYING LIPOSOME-ENCAPSULATED POLYPEPTIDES | PITMAN-MOORE, INC. (US) | 1993-03-18 | — | — | WO | claimed |
| US-20260130856-A1 | LIPOSOME COMPOSITIONS FOR DELIVERY OF COMPOUNDS AND METHODS THEREOF | NANOTECH PHARMA INC (US) | 2026-05-14 | — | — | US | disclosed |
| CN-115246867-B | Method for synthesizing 7-ketolithocholic acid by taking BA as raw material | 江苏佳尔科药业集团股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20250319190-A1 | APOE LIPOPROTEIN SYSTEMS | KISBEE THERAPEUTICS INC (US) | 2025-10-16 | — | — | US | disclosed |
| US-20250263612-A1 | Hydrodeoxygenation of Phenolic Lipids and Renewable Hydrocarbon Fuels Produced Therefrom | RENEWABLE ENERGY GROUP, INC. (US) | 2025-08-21 | — | — | US | disclosed |
| EP-4601621-A1 | LIPOSOME COMPOSITIONS FOR DELIVERY OF COMPOUNDS AND METHODS THEREOF | Nanotech Pharma Inc. (US) | 2025-08-20 | — | — | EP | disclosed |
| EP-4583883-A2 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF NUCLEIC ACID-BASED THERAPEUTICS AND METHODS THEREOF | Nanotech Pharma Inc. (US) | 2025-07-16 | — | — | EP | disclosed |
| US-12275906-B2 | Hydrodeoxygenation of phenolic lipids and renewable hydrocarbon fuels produced therefrom | RENEWABLE ENERGY GROUP, INC. (US) | 2025-04-15 | — | — | US | disclosed |
| EP-4522646-A2 | APOE LIPOPROTEIN SYSTEMS | Kisbee Therapeutics, Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| WO-1988001274-A1 | ACTIVE PRINCIPLE ISOLATED FROM SHARK TISSUES | BROADBENT, JAMES, MEREDYTH (AU) | 1988-02-25 | — | — | WO | disclosed |
| WO-1986004893-A1 | PROCESS FOR THE PREPARATION OF ALKYL FLUORIDES | ZAMBON S.P.A. (IT) | 1986-08-28 | — | — | WO | disclosed |
| US-4189431-A | CYCLIZATION OF POLYENINE TO POLYCYCLIC COMPOUND HAVING CYCLOPENTANO RING | The Board of Trustees of Leland Stanford Junior University (US) | 1980-02-19 | — | — | US | disclosed |
| US-4129599-A | A-Norsteroids | THE BOARD OF TRUSTEES OF LELAND STANFORD JR. UNIVERSITY (US) | 1978-12-12 | — | — | US | disclosed |
| US-4064185-A | Olefinically unsaturated substituents at C-11 of steroid cyclization precursors | THE BOARD OF TRUSTEES OF LELAND STANFORD JUNIOR UNIVERSITY (US) | 1977-12-20 | — | — | US | disclosed |
| US-4055603-A | HORMONES | THE BOARD OF TRUSTEES OF LELAND STANFORD JUNIOR UNIVERSITY (US) | 1977-10-25 | — | — | US | disclosed |
| US-4032579-A | POLY-UNSATURATED HYDROXY-ALKYNYL CYCLOPENTENOL | THE BOARD OF TRUSTEES OF LELAND STANFORD JUNIOR UNIVERSITY (US) | 1977-06-28 | — | — | US | disclosed |
| US-3998859-A | Introducing Δ11 unsaturation into steroid compounds | EASTMAN KODAK COMPANY (US) | 1976-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12275906-B2 | Hydrodeoxygenation of phenolic lipids and renewable hydrocarbon fuels produced therefrom | ALOX15, ALOX12, ALOX15B | CYP2D6 157/4885CYP2C19 465/4885EPHA2 3357/4885 |
| US-20250319190-A1 | APOE LIPOPROTEIN SYSTEMS | APOB, APOL1, LDLR | CYP2D6 1367/4885CYP2C19 2443/4885EPHA2 74/4885 |
| US-20260130856-A1 | LIPOSOME COMPOSITIONS FOR DELIVERY OF COMPOUNDS AND METHODS THEREOF | SGMS2, SGMS1, LIPA | CYP2D6 2933/4885CYP2C19 3246/4885EPHA2 294/4885 |
| US-20250263612-A1 | Hydrodeoxygenation of Phenolic Lipids and Renewable Hydrocarbon Fuels Produced Therefrom | ALOX15, ALOX12, ALOX15B | CYP2D6 157/4885CYP2C19 465/4885EPHA2 3357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.